Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diroximel Fumarate for Perihaematomal Oedema in Intracerebral Haemorrhage
NCT07275515Phase 2Recruiting
- Sponsor
- CHU de Lille
- Start
- May 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diroximel fumarate in intracerebral hemorrhage (ICH), sponsored by CHU de Lille. Started May 2026; status: recruiting.
02
Drugs
diroximel fumarate
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07275515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07275515.